Times Square Capital Management, LLC Nex Immune, Inc. Transaction History

Times Square Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$1.79 - $4.65 $387,339 - $1.01 Million	-216,391 Closed	0 $0
Q4 2021 Feb 04, 2022	SELL	$4.11 - $15.13 $978,833 - $3.6 Million	-238,159 Reduced 52.39%	216,391 $998,000
Q3 2021 Nov 08, 2021	SELL	$10.32 - $16.9 $284,316 - $465,594	-27,550 Reduced 5.71%	454,550 $6.88 Million
Q2 2021 Aug 09, 2021	SELL	$14.98 - $23.89 $74,900 - $119,450	-5,000 Reduced 1.03%	482,100 $7.87 Million
Q1 2021 May 12, 2021	BUY	$17.95 - $25.91 $8.74 Million - $12.6 Million	487,100 New	487,100 $9.29 Million

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $5.07M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Times Square Capital Management, LLC with notifications on news.